Healthcare - Biotechnology - NASDAQ - IL
$ 2.93
-5.48 %
$ 4.42 M
Market Cap
-0.27
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
-0.00%
Net Income
Estimate
26.03%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Galmed Pharmaceuticals Ltd.
GLMD has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart GLMD
EBIT FORECAST
EBIT Forecast Chart GLMD
NET INCOME FORECAST
Net Income Chart GLMD